HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) 30 mL Plungerless Si...

FDA Recall #D-0196-2021 — Class II — December 17, 2020

Recall #D-0196-2021 Date: December 17, 2020 Classification: Class II Status: Terminated

Product Description

HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) 30 mL Plungerless Single Dose Syringe (barcode 70004030316) and b) 30 mL Single Dose Syringe (barcode 70004030321), Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095

Reason for Recall

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling Firm

SCA Pharmaceuticals — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,056 syringes

Distribution

Product was distributed to hospitals nationwide.

Code Information

a) Lot # 1220022964, BUD 1/19/2021; 1220023280, BUD 2/1/2021 & 1220023623, BUD 2/10/2021. b) Lot # 1220023347, BUD 2/17/2021.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated